TSVT — 2Seventy Bio Share News
0.000.00%
Last trade - 00:00- $265.62m
- $95.24m
- $37.86m
US FDA panel votes in favor of expanded use of Bristol Myers' CAR-T therapy
U.S. STOCKS ON THE MOVE-Vera Bradley, Rumble, Nvidia
U.S. STOCKS ON THE MOVE-Williams-Sonoma, US energy sector, gold miners
J&J, 2seventy bio fall after US FDA raises concerns over CAR-T therapy data
US FDA staff flags safety concerns from J&J, Bristol's CAR-T therapies (updated)
US FDA staff flag safety concerns from J&J, Bristol's CAR-T therapies
2Seventy Bio Inc reports results for the quarter ended in December - Earnings Summary
Brief: Bristol Myers Squibb And 2seventy bio Share Update
U.S. RESEARCH ROUNDUP- Advanced Micro Devices, HCA Healthcare, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Kura Oncology , Vertex Pharma, Nucor
U.S. STOCKS ON THE MOVE-SLB, Corning, 2seventy Bio
2seventy bio up on selling experimental cell therapies to Regeneron
2seventy bio to sell experimental cell therapies to Regeneron (updated)
Brief: 2seventy bio To Sell R&D Pipeline To Regeneron
Regeneron to buy development rights to 2seventy bio's cell therapies
Brief: EMA Says CHMP Adopted Positive Opinion Recommending Change On Marketing Authorisation For Abecma
US FDA requires 'boxed warning' for CAR-T cancer therapies (updated)
US FDA requires 'boxed warning' for CAR-T cancer therapies
Brief: FDA Requires Gilead, JNJ, Novartis, Bristol Myers Squibb, 2Seventy Bio, Legend Biotech To Add Safety Warning To Car-T Therapies - Website